Results 211 to 220 of about 11,054,575 (256)

Probing Intracellular Yeast Metabolism With Deuterium Magnetic Resonance Spectroscopy. [PDF]

NMR Biomed
Anum F, Assaf C, Haj Mohamad F, Anikeeva M, Brahms A, Dey J, Kaltenberger S, Beitz E, Welz L, Annis V, van Gemmeren M, Duckett S, Hövener JB, Pravdivtsev AN.   +13 more
europepmc   +1 more source

Pain, Stress and Mental Well-Being Over Three Generations. [PDF]

Eur J Pain
Stanisic N, Sharma S, Vallin S, Nilsson PM, Östergren PO, Lövgren A, List T, Häggman-Henrikson B.   +7 more
europepmc   +1 more source

The Developmental Trajectories of Attentional Biases and Their Association With Internalising Symptoms in Children Transitioning Into Early Adolescence. [PDF]

Int J Psychol
Zhang Q, Wang Y, Ho SMY.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Naloxone

Annals of Emergency Medicine, 1983
Naloxone hydrochloride, a synthetic N-allyl derivative of oxymorphone, is an effective agent for the reversal of the cardiovascular and respiratory depression associated with narcotic and possibly some non-narcotic overdoses. It is essentially a pure narcotic antagonist, is relatively safe, and is a useful diagnostic and therapeutic agent.
K A, Handal, J L, Schauben, F R, Salamone   +2 more
openaire   +2 more sources

Naloxone for shock

Cochrane Database of Systematic Reviews, 2003
There is pre-clinical evidence, involving several animal species, suggesting that opioid peptides play a role in the physiopathology of shock (endotoxic, hypovolemic, cardiogenic, spinal, anaphylactic). Many case reports have suggested that naloxone (an opiate antagonist) might be an effective treatment for shock in humans, but others have not ...
B, Boeuf, V, Poirier, F, Gauvin, A M, Guerguerian, C, Roy, C A, Farrell, J, Lacroix   +6 more
openaire   +3 more sources

Naloxone and Alcoholic Intoxication

Annals of Internal Medicine, 1982
Excerpt To the editor: In a recent article, Lyon and Antony (1) reported the dramatic effect of naloxone hydrochloride in two comatose patients with alcoholic intoxication.
Lignian, Hervé, Fontaine, Jeanine, Askenasi, Robert   +2 more
openaire   +3 more sources

Perinatal naloxone: When does naloxone affect hyperalgesia?

Pharmacology Biochemistry and Behavior, 1979
Pregnant mice were treated with naloxone via subcutaneous implants, from about 5 days prior to parturition. At birth entire litters were cross-fostered so that groups of offspring were exposed to naloxone treated mothers; before birth, after birth to weaning, from about 5 days prior to birth to weaning, or not exposed to naloxone.
Harvey Monder, John J. Christian, Norie Yasukawa   +2 more
openaire   +3 more sources

Naloxone in Hepatic Encephalopathy

Archives of Pediatrics & Adolescent Medicine, 1985
Sir .—The prognosis of hepatic encephalopathy in general is extremely guarded. By using levodopa (100 mg/kg), 23 of 39 patients with hepatic encephalopathy related to different liver diseases responded to treatment, and 17 of them were discharged in an uncontrolled study.
Şinasi Özsoylu, Nurten Koçak
openaire   +3 more sources

Intranasal Naloxone Administration

New England Journal of Medicine, 2021
Intranasal Administration of Naloxone Intranasal naloxone is used to treat patients with respiratory and central nervous system depression that is known or suspected to be caused by an opioid overd...
Rafael Ortega, Ala Nozari, William Baker, Sannoor Surani, Melinda Edwards   +4 more
openaire   +3 more sources

Naloxone-lnduced Lethargy

Archives of General Psychiatry, 1981
To the Editor.— The article by Judd et al, "Naloxone-Induced Behavioral and Physiological Effects in Normal and Manic Subjects" (Archives1980; 37:583-586), states that lethargy is the main behavioral effect of naloxone hydrochloride in manic patients and normal controls.
Yasuko F. Jacquet, Jan Volavka
openaire   +3 more sources